Search
05/01/2023
One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients
Pinana, JL, Vazquez, L, Calabuig, M, Lopez-Corral, L, Martin-Martin, G, Villalon, L, Sanz-Linares, G, Conesa-Garcia, V, Sanchez-Salinas, A, Gago, B, Facal, A, Risco-Galvez, I, Olave, MT, Espigado, I, Lopez-Jimenez, J, Hernandez-Rivas, JA, Avendano-Pita, A, Arroyo, I, Ferrer, E, Garcia-Cadenas, I, Gonzalez-Santillana, C, Roldan-Perez, A, Ferrer, B, Guerreiro, M, Suarez-Lledo, M, Camara, A, Campos-Beltran, D, Navarro, D, Cedillo, A, Sureda, A, Solano, C, Martino, R. One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients. Blood Cancer Journal. 2023; 13(1)DOI:10.1038/s41408-022-00778-3. PMID:36599843. IF:12.900(Q1/1D).
02/01/2023
Sorting Transcriptomics Immune Information from Tumor Molecular Features Allows Prediction of Response to Anti-PD1 Therapy in Patients with Advanced Melanoma
Trilla-Fuertes L., Gámez-Pozo A., Prado-Vázquez G., López-Vacas R., Zapater-Moros A., López-Camacho E., Lumbreras-Herrera M.I., Soriano V., Garicano F., Lecumberri M.J., de la Borbolla, MR, Majem M., Pérez-Ruiz E., González-Cao M., Oramas J., Magdaleno A., Fra J., Martín-Carnicero A., Corral M., Puértolas T., Ramos R., Vara, JAF, Espinosa E.. Sorting Transcriptomics Immune Information from Tumor Molecular Features Allows Prediction of Response to Anti-PD1 Therapy in Patients with Advanced Melanoma. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(1)DOI:10.3390/ijms24010801. PMID:36614248. IF:4.900(Q1/3D).
01/01/2023
Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants
Meinel T.R., Wilson D., Gensicke H., Scheitz J.F., Ringleb P., Goganau I., Kaesmacher J., Bae H.-J., Kim D.Y., Kermer P., Suzuki K., Kimura K., Macha K., Koga M., Wada S., Altersberger V., Salerno A., Palanikumar L., Zini A., Forlivesi S., Kellert L., Wischmann J., Kristoffersen E.S., Beharry J., Barber P.A., Hong J.B., Cereda C., Schlemm E., Yakushiji Y., Poli S., Leker R., Romoli M., Zedde M., Curtze S., Ikenberg B., Uphaus T., Giannandrea D., Portela P.C., Veltkamp R., Ranta A., Arnold M., Fischer U., Cha J.-K., Wu T.Y., Purrucker J.C., Seiffge D.J., Kägi G., Engelter S., Nolte C.H., Kallmünzer B., Michel P., Kleinig T.J., Fink J., Rønning O.M., Campbell B., Nederkoorn P.J., Thomalla G., Kunieda T., Poli K., Béjot Y., Soo Y., Garcia-Esperon C., Ntaios G., Cordonnier C., Marto J.P., Bigliardi G., Lun F., Choi P.M.C., Steiner T., Ustrell X., Werring D., Wegener S., Pezzini A., Du H., Martí-Fàbregas J., Cánovas-Vergé D., Strbian D., Padjen V., Yaghi S., Stretz C., Kim J.-T.. Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants. JAMA Neurology. 2023; 80(3)DOI:10.1001/jamaneurol.2022.4782. PMID:36807495. IF:20.900(Q1/1D).
01/01/2023
Loss of function variants in DNAJB4 cause a myopathy with early respiratory failure
Weihl C.C., Topf, A, Bengoechea R., Duff J., Charlton R., Garcia S.K., Domínguez-González C., Alsaman A., Hernández-Laín A., Franco L.V., Sanchez, MEP, Beecroft S.J., Goullee H., Daw J., Bhadra A., True H., Inoue M., Findlay A.R., Laing N., Olivé M., Ravenscroft G., Straub V.. Loss of function variants in DNAJB4 cause a myopathy with early respiratory failure. ACTA NEUROPATHOLOGICA. 2023; 145(1)DOI:10.1007/s00401-022-02510-8. PMID:36264506. IF:9.300(Q1/1D).
01/01/2023
Muscle MRI in immune-mediated necrotizing myopathy (IMNM): implications for clinical management and treatment strategies
Fionda, L, Lauletta, A, Leonardi, L, Perez, JA, Morino, S, Merlonghi, G, Alfieri, G, Costanzo, R, Tufano, L, Vanoli, F, Rossini, E, Vigo, EG, Tartaglione, T, Salvetti, M, Antonini, G, Diaz-Manera, J, Garibaldi, M. Muscle MRI in immune-mediated necrotizing myopathy (IMNM): implications for clinical management and treatment strategies. JOURNAL OF NEUROLOGY. 2023; 270(2)DOI:10.1007/s00415-022-11447-7. PMID:36329184. IF:4.800(Q1/2D).
01/01/2023
New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy (vol 143, pg 2696, 2020)
Alonso-Perez, J, Gonzalez-Quereda, L, Bello, L, Guglieri, M, Straub, V, Gallano, P, Semplicini, C, Pegoraro, E, Zangaro, V, Nascimento, A, Ortez, C, Comi, GP, ten Dam, L, De Visser, M, van der Kooi, AJ, Garrido, C, Santos, M, Schara, U, Gangfuss, A, Lokken, N, Storgaard, JH, Vissing, J, Schoser, B, Dekomien, G, Udd, B, Palmio, J, D'Amico, A, Politano, L, Nigro, V, Bruno, C, Panicucci, C, Sarkozy, A, Abdel-Mannan, O, Alonso-Jimenez, A, Claeys, KG, Gomez-Andres, D, Munell, F, Costa-Comellas, L, Haberlova, J, Rohlenova, M, Elke, D, De Bleecker, JL, Dominguez-Gonzalez, C, Tasca, G, Weiss, C, Deconinck, N, Fernandez-Torron, R, de Munain, AL, Camacho-Salas, A, Melegh, B, Hadzsiev, K, Leonardis, L, Koritnik, B, Garibaldi, M, de Leon-Hernandez, JC, Malfatti, E, Fraga-Bau, A, Richard, I, Illa, I, Diaz-Manera, J. New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy (vol 143, pg 2696, 2020). BRAIN. 2023; 146(1)DOI:10.1093/brain/awac371. PMID:. IF:11.900(Q1/1D).